Renal tubular defects: Pathology review

8,943views

Renal tubular defects: Pathology review

Step 1

Step 1

Tuberculosis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Breast cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Uterine stimulants and relaxants
Aromatase inhibitors
Progestins and antiprogestins
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Osmotic diuretics
Loop diuretics
Potassium sparing diuretics
Carbonic anhydrase inhibitors
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
General anesthetics
Local anesthetics
Neuromuscular blockers
Back pain: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Seronegative and septic arthritis: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Bone disorders: Pathology review
Bone tumors: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Pigmentation skin disorders: Pathology review
Acneiform skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Skin cancer: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
Inflammatory bowel disease: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Gastrointestinal bleeding: Pathology review
Appendicitis: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Vertigo: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes mellitus: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Multiple endocrine neoplasia: Pathology review
Diabetes insipidus and SIADH: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Hypertension: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Glycogen storage disorders: Pathology review
Dyslipidemias: Pathology review
Lysosomal storage disorders: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review

Transcript

Watch video only

In the Emergency Department, two people came in. One of them is 40-year-old Sarah, who came in with rapid, shallow breathing and tachycardia. The other one is 35-year-old Alfred, who came in with slow and shallow breathing. Arterial blood gas was taken, along with electrolytes. Results showed that Sarah had low blood pH, bicarbonate and pCO2 levels and her potassium level was also low. Alfred had a high pH, bicarbonate and pCO2 levels, but his potassium level was low.

Based on these results, Sarah was diagnosed with metabolic acidosis, while Alfred had metabolic alkalosis. Further investigations were done, like electrolytes and urinalysis. This showed that Sarah had hypophosphatemia and urinalysis showed phosphaturia, aminoaciduria and glucosuria, while Fred had hypokalemia and urinalysis showed hypercalciuria. Now, the results from the labs of both individuals point towards some kind of renal tubular defect that’s causing acid-base disorders.

Before talking specifics, let's remember the physiology of the renal tubules. The proximal convoluted tubule or PCT reabsorbs bicarbonate, all glucose, uric acid and amino acids. Apart from this, it also reabsorbs water, potassium, chloride, phosphate and most of the sodium, as well as most of the calcium. PCT also secretes hydrogen and phosphate into the urine.

The thin descending loop of Henle reabsorbs water and that’s pretty much it. The thick ascending loop of Henle or TAL, on the other hand, reabsorbs potassium, chloride and sodium. Now, in order to reabsorb sodium, potassium and chloride, there’s a Na/K/Cl cotransporter or NKCC2, that’s only found in the kidney and its role is to snatch these ions from the urine and reabsorb them. Apart from this, TAL can also reabsorb calcium and most of the magnesium but doesn’t reabsorb water.

Now, the distal convoluted tubule or DCT reabsorbs sodium and chloride, through a sodium-chloride cotransporter, as well as calcium and some magnesium. Again, it does not reabsorb water. Finally, the collecting tubule is regulated by aldosterone and reabsorbs sodium in exchange for potassium and hydrogen. Now, aldosterone acts on mineralocorticoid receptors and in the principal cells of the collecting tubule, which leads to potassium secretion, while in the -intercalated cells, leads to hydrogen secretion.

Alright, let’s now talk about tubular defects, which are a group of disorders that affect the renal tubules. Tubular defects are usually genetic, but they can also be acquired. The PCT can be affected by Fanconi syndrome. The thick ascending loop of Henle can be affected by Bartter syndrome, while the DCT can be affected by Gitelman syndrome. The collecting tubule can be affected by Liddle syndrome. Finally, there’s syndrome of apparent mineralocorticoid excess or SAME which also affects the collecting tubule.

Let’s start talking about Fanconi syndrome which is a generalized reabsorption defect in the PCT. Now, Fanconi syndrome can be hereditary or acquired. Hereditary Fanconi syndrome can be caused by inherited disorders like Wilson’s disease. With this disease, there’s a defect in the copper-transporting protein and this leads to accumulation of copper in various tissues. It primarily affects the liver, but other organs, like the brain, cornea and the kidney’s PCT are also affected, the latter can lead to Fanconi syndrome.

Another example is tyrosinemia, which is caused by mutations in some enzymes needed for tyrosine metabolism. There are several mutations involved, but the key fact is that depending on where the tyrosine metabolism is affected, this can result in the accumulation of tyrosine or its byproducts in different organs, like the liver, kidneys and peripheral nerves. Now, all that tyrosine or byproduct accumulation is toxic for the proximal tubule and this can result in Fanconi syndrome.

Finally, there’s glycogen storage disease, which is a group of genetic conditions that affect either glycogen synthesis or the breakdown of glycogen or glucose. There are several mutations involved, but when glycogen metabolism is affected, this can result in the accumulation of glycogen in the liver and kidneys. Just like with tyrosinemia, all that glycogen can be toxic to the PCT and result in Fanconi syndrome.

Alright, next there’s acquired Fanconi syndrome that can happen with ischemia. Now, renal ischemia has a lot of causes, like hypovolemia, which in turn also has many causes, like diarrhea or acute hemorrhage. Now, hypovolemia leads to less blood flow to the kidneys, and this means that the cells are not getting all the blood supply and nutrients they need, and this can damage the PCT, leading to Fanconi syndrome.

Another condition is multiple myeloma, which can cause proximal tubular dysfunction. Now, multiple myeloma is a monoclonal gammopathy where there’s a proliferation of plasma cells in the bone marrow. These plasma cells secrete many abnormal immunoglobulins which are then filtered in the kidneys and are pretty toxic for the proximal tubule and as a result, this can lead to Fanconi syndrome. Then, there are nephrotoxic drugs, like ifosfamide, cisplatin or expired tetracycline and heavy metal exposure, like lead poisoning that can damage the PCT.

Alright, now, since the entire proximal tubule is damaged, it won’t be able to reabsorb things like bicarbonate, sodium, glucose, phosphate, uric acid, etc, and they are lost in the urine. Now, when bicarbonate isn’t reabsorbed in the proximal tubule it can lead to proximal renal tubular acidosis, or type II renal tubular acidosis, or type II RTA. Here, a lot of bicarbonate is lost in the urine and as a result, serum bicarbonate levels fall, leading to acidemia and metabolic acidosis. Another important fact to remember is that since phosphate is lost in the urine, there’s also hypophosphatemia which in turn decreases bone mineralization, so these people often suffer from osteopenia.

Next, let’s move onto the loop of Henle and look at Bartter syndrome, which is an autosomal recessive condition. This is a defect that causes a mutation in the NKCC2 cotransporter in the thick ascending loop of Henle, leading to loss of sodium, potassium, and chloride in the urine. Even though there’s more sodium lost through the urine, more water is lost with it, so typically, there’s no hyponatremia. However, the potassium lost through urine will lead to hypokalemia. Also, in the thick ascending loop of Henle, calcium is reabsorbed with the help of an electrochemical gradient that’s created by the movement of sodium, chloride and potassium.

Another high yield fact to remember is that when these ions are lost, calcium also can’t be reabsorbed, leading to hypercalciuria.

Now, the loss of all these ions in the urine causes volume contraction or excessive loss of extracellular volume. This in turn triggers the renin-angiotensin-aldosterone system. As a result, angiotensin II and aldosterone levels rise, and the kidneys start to secrete more potassium and H+ while reabsorbing more bicarbonate in the PCT, and serum bicarbonate levels rise, leading to metabolic alkalosis.

Alright, for your exam, a high yield fact is that loop diuretics also block the NKCC2 cotransporter in the thick ascending loop of Henle, which means that Bartter syndrome presents almost like chronic loop diuretic use.

Key Takeaways

Renal tubular defects refer to a group of disorders that affect the tubules of the kidneys. These tubules are responsible for filtering waste products from the blood, reabsorbing essential nutrients, and regulating the balance of electrolytes in the body. When these tubules are damaged or malfunctioning, they can lead to a variety of symptoms and complications, such as electrolyte imbalances, acid-base disturbances, and kidney failure. Some examples of renal tubular defects include Fanconi syndrome, Bartter syndrome, and Gitelman syndrome.

In Fanconi syndrome, there is a dysfunction of the proximal convoluted tubule (PCT), which results in the excretion of all substances normally reabsorbed by the PCT, such as glucose, bicarbonate, etc. In Bartter syndrome, there are defects in Na+/K+/2Cl- cotransporter in the thick ascending loop of Henle, which lead to metabolic alkalosis, hypokalemia, and hypercalciuria. Finally, in Gitelman syndrome, there is defective reabsorption of sodium chloride in the distal convoluted tubules (DCT), which leads to metabolic alkalosis, hypomagnesemia, hypokalemia, and hypocalciuria. Treatment options may include medications, dietary changes, and in some cases, kidney transplants.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Practical Renal Pathology, A Diagnostic Approach E-Book" Elsevier Health Sciences (2012)
  4. "Physiology E-Book" Elsevier Health Sciences (2017)
  5. "The Renal System" Churchill Livingstone (2010)
  6. "Nephrolithiasis related to inborn metabolic diseases" Pediatric Nephrology (2009)
  7. "Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome" JCI Insight (2018)
  8. "Fanconi Syndrome" Pediatric Clinics of North America (2019)